icon-    folder.gif   Conference Reports for NATAP  
 
  Conference on Retroviruses
and Opportunistic Infections
San Francisco, CA
March 9-12 2025
Back grey_arrow_rt.gif
 
 
 
DoxyPEP Eligibility, Use, and Potential for STI Reduction in a Large HIV Cohort in Washington, DC...."early uptake of DoxyPEP was minimal, yet a majority of PWH were DoxyPEP eligible"
 
 
  CROI 2025 SF March 9-12
 
Amanda D. Castel, MD, MPH
DC Cohort Study, Principal Investigator
Professor, Department of Epidemiology
The George Washington University Milken Institute School of Public Health

0325251

0325252

0325253

0325254

0325255

0325256

0325257

0325258

0325259

03252510